Zenas BioPharma, Inc.
ZBIONASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $1.60B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $13.50$44.60
- Volume (live)
- -
- Avg. volume (3M)
- 668.00K
Zenas BioPharma (ZBIO) Stock Price & Financial Analysis
Zenas BioPharma Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $24.51 - $25.96 |
|---|---|
| 52-Week High | $44.60 |
| 52-Week Low | $13.50 |
| Open | $25.36 |
| Volume (last close) | 661.70K |
| Average Volume (3M) | 668.00K |
| Revenue (TTM) | 1.00M |
|---|---|
| Net Income (TTM) | -484.38M |
| Free Cash Flow (TTM) | -255.97M |
| EPS (TTM) | −$9.34 |
| Profit Margin | -48438.40% |
| Operating Margin | -44557.30% |
| Return on Equity (ROE) | -196.03% |
| Debt to Equity | 1.21 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 1.60B |
|---|---|
| Shares Outstanding | 63.11M |
| Price to Sales (P/S) | 1603.05 |
| Price to Book (P/B) | 6.49 |
| EV/EBITDA | -3.93 |
| 50-Day MA | $30.43 |
|---|---|
| 200-Day MA | $24.77 |
| 1-Year Change | +6.05% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Zenas BioPharma at a Glance
As of the Oct 16, 2026 close, Zenas BioPharma (ZBIO) has a market capitalization of $1.60B. The stock trades at 1603.0× sales. Over the trailing twelve months it lost $484.38M on revenue of $1.00M and burned $255.97M of free cash flow. Revenue fell 93.3% year over year.
As of its latest reported balance sheet, it holds $196.58M in cash and securities against $297.84M of debt, a net debt position of $101.26M.
Zenas BioPharma does not currently pay a dividend.
The share price is up 6.1% over the past year. At $24.84 (the Oct 16, 2026 close) it sits within its 52-week range of $13.50 to $44.60, above its 200-day moving average of $24.77.
Based on 5 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $44.80, 80.4% above the Oct 16, 2026 close.
Frequently Asked Questions About Zenas BioPharma
What is the current stock price for ZBIO?
As of the Oct 16, 2026 close, ZBIO stock trades at $24.84. The 52-week range is $13.50–$44.60, with a day range of $24.51–$25.96.
What is the P/E ratio for ZBIO?
The P/E ratio (Price-to-Earnings) for ZBIO is shown in the Key Statistics section. This valuation metric helps compare Zenas BioPharma, Inc. to industry peers.
Does ZBIO pay dividends?
Zenas BioPharma does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for ZBIO?
Based on ratings from 5 professional analysts over the last 90 days, the consensus for ZBIO is Buy. The average 12-month price target is $44.80, a 80.4% upside from the Oct 16, 2026 close of $24.84.
What is the market cap of ZBIO?
As of the Oct 16, 2026 close, Zenas BioPharma's market capitalization is $1.57B, classifying it as a small-cap company. Zenas BioPharma operates in the Healthcare sector within the Biotechnology industry.